All Stories

  1. Static autoregulation in humans
  2. Characterization of gray matter volume changes from one week to 6 months after termination of electroconvulsive therapy in depressed patients
  3. Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
  4. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
  5. Ictal and interictal SPECT with 99mTc‐HMPAO in presurgical epilepsy. II: Methodological considerations on hyper‐ and hypoperfusion
  6. Ictal and interictal SPECT with 99mTc‐HMPAO in presurgical epilepsy. I: Predictive value and methodological considerations
  7. The history of Danish neuroscience
  8. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
  9. Single-Voxel MR Spectroscopy of Gliomas with s-LASER at 7T
  10. Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study
  11. Correction: Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinated fasciculus microstructure
  12. Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration
  13. Human Cerebral Perfusion, Oxygen Consumption, and Lactate Production in Response to Hypoxic Exposure
  14. Do glia provide the link between low‐grade systemic inflammation and normal cognitive ageing? A 1 H magnetic resonance spectroscopy study at 7 tesla
  15. Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy
  16. Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinate fasciculus microstructure
  17. Interictal pontine metabolism in migraine without aura patients: A 3 Tesla proton magnetic resonance spectroscopy study
  18. Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy
  19. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing
  20. Blood pressure and brain injury in cardiac surgery: a secondary analysis of a randomized trial
  21. Intradural artery dilation during experimentally induced migraine attacks
  22. Transcranial low‐frequency pulsating electromagnetic fields (T‐PEMF) as post‐concussion syndrome treatment
  23. Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labeling
  24. Cigarette smoking and cerebral blood flow in a cohort of middle-aged adults
  25. Regional glia-related metabolite levels are higher at older age and scale negatively with visuo-spatial working memory: A cross-sectional proton MR spectroscopy study at 7 tesla on normal cognitive ageing
  26. Diagnostic yield of high-density versus low-density EEG: The effect of spatial sampling, timing and duration of recording
  27. Diagnostic added value of electrical source imaging in presurgical evaluation of patients with epilepsy: A prospective study
  28. The association between postoperative cognitive dysfunction and cerebral oximetry during cardiac surgery: a secondary analysis of a randomised trial
  29. No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intake
  30. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed
  31. Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study
  32. Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study
  33. Domain‐specific cognitive dysfunction after cardiac surgery. A secondary analysis of a randomized trial
  34. Previous glucocorticoid treatment in childhood and adolescence is associated with long-term differences in subcortical grey matter volume and microstructure
  35. Neuroticism predicts the impact of serotonin challenges on fear processing in subgenual anterior cingulate cortex
  36. Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy
  37. Gamma‐aminobutyric acid edited echo‐planar spectroscopic imaging (EPSI) with MEGA‐sLASER at 7T
  38. Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers
  39. Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T
  40. Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study
  41. Verbal learning and memory outcome in selective amygdalohippocampectomy versus temporal lobe resection in patients with hippocampal sclerosis
  42. High-Target vs Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients - A Randomized Controlled Trial
  43. Total brain, cortical, and white matter volumes in children previously treated with glucocorticoids
  44. Neural Response After a Single ECT Session During Retrieval of Emotional Self-Referent Words in Depression: A Randomized, Sham-Controlled fMRI Study
  45. Glucocorticoid treatment earlier in childhood and adolescence show dose-response associations with diurnal cortisol levels
  46. Imaging Regional Metabolic Changes in the Ischemic Rat Heart In Vivo Using Hyperpolarized [1- 13 C]Pyruvate
  47. Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla
  48. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study
  49. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders
  50. Perfusion Pressure Cerebral Infarct (PPCI) trial - the importance of mean arterial pressure during cardiopulmonary bypass to prevent cerebral complications after cardiac surgery: study protocol for a randomised controlled trial
  51. Neural correlates of improved executive function following erythropoietin treatment in mood disorders
  52. The Center for Integrated Molecular Brain Imaging (Cimbi) database
  53. Design of Infusion Schemes for Neuroreceptor Imaging: Application to [11C]Flumazenil-PET Steady-State Study
  54. Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
  55. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
  56. Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression
  57. Children and adolescents previously treated with glucocorticoids display lower verbal intellectual abilities
  58. Shape Abnormalities of the Caudate Nucleus Correlate with Poorer Gait and Balance: Results from a Subset of the LADIS Study
  59. Interpolation of diffusion weighted imaging datasets
  60. CorticalN-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis
  61. Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV‐PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1‐13C]pyruvate
  62. Multiple sclerosis impairs regional functional connectivity in the cerebellum
  63. Bradykinin Antagonist Counteracts the Acute Effect of Both Angiotensin-Converting Enzyme Inhibition and of Angiotensin Receptor Blockade on the Lower Limit of Autoregulation of Cerebral Blood Flow
  64. Serotonin 2A receptors contribute to the regulation of risk-averse decisions
  65. In Memoriam: Bo K Siesjö, 1930–2013
  66. Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion
  67. A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging
  68. Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression
  69. Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala
  70. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study
  71. Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks
  72. Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis
  73. Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: A longitudinal analysis
  74. Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
  75. Serotonin 2A Receptors, Citalopram and Tryptophan-Depletion: a Multimodal Imaging Study of their Interactions During Response Inhibition
  76. Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis
  77. Healthy aging attenuates task-related specialization in the human medial temporal lobe
  78. No change in [11C]CUMI-101 binding to 5-HT1A receptors after intravenous citalopram in human
  79. The cortical eye proprioceptive signal modulates neural activity in higher-order visual cortex as predicted by the variation in visual sensitivity
  80. Sandstone hosted uranium deposits of the Great Divide Basin, Wyoming, USA
  81. Activation of the hippocampal complex during tactile maze solving in congenitally blind subjects
  82. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study
  83. Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis
  84. The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study
  85. Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study
  86. Crossmodal Recruitment of the Ventral Visual Stream in Congenital Blindness
  87. Neural Metabolism In Vivo
  88. History of International Society for Cerebral Blood Flow and Metabolism
  89. The Coupling of Cerebral Metabolic Rate of Glucose and Cerebral Blood Flow In Vivo
  90. White matter hyperintensities and prepulse inhibition in a mixed elderly population
  91. Postoperative increase in grey matter volume in visual cortex after unilateral cataract surgery
  92. Exogenous glucocorticoids and adverse cerebral effects in children
  93. White Matter Microstructure in Superior Longitudinal Fasciculus Associated with Spatial Working Memory Performance in Children
  94. Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: A 3-year follow-up of the LADIS study cohort
  95. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue
  96. Neural correlates of olfactory processing in congenital blindness
  97. Incident lacunes influence cognitive decline: The LADIS study
  98. Monocular Visual Deprivation Suppresses Excitability in Adult Human Visual Cortex
  99. 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?
  100. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
  101. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding
  102. White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study
  103. Hippocampal volume changes in healthy subjects at risk of unipolar depression
  104. Neural correlates of virtual route recognition in congenital blindness
  105. Response inhibition is associated with white matter microstructure in children
  106. Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia
  107. Methods for observing the living brain
  108. Regional activation of the human medial temporal lobe during intentional encoding of objects and positions
  109. Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding
  110. Cerebral Blood Flow Response to Functional Activation
  111. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study
  112. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram vers...
  113. No Evidence for Generalized Increased Postoperative Responsiveness to Pain: A Combined Behavioral and Serial Functional Magnetic Resonance Imaging Study
  114. Corrigendum to “Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use” [NeuroImage 46 (2009) 23–30]
  115. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort
  116. Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use
  117. A Case of Malignant Lymphoma and Myasthenia Gravis
  118. THE EFFECTS OF SODIUM NITROPRUSSIDE ON CEREBRAL BLOOD FLOW AND CEREBRAL VENOUS BLOOD GASES IN MAN
  119. ACID-BASE PATTERN OF CEREBROSPINAL FLUID AND ARTERIAL BLOOD IN BACTERIAL MENINGITIS AND IN ENCEPHALITIS
  120. REGIONAL CEREBRAL BLOOD FLOW, CEREBRAL METABOLIC RATE OF OXYGEN, AND CEREBROSPINAL FLUID ACID-BASE VARIABLES IN PATIENTS WITH ACUTE MENINGITIS AND WITH ACUTE ENCEPHALITIS
  121. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
  122. Transfer of bromocriptine across the blood-brain barrier in man
  123. Skeletal muscle in paramyotonia congenita: biochemistry, histochemistry and morphology
  124. PHYSIOLOGIC AND PATHOPHYSIOLOGIC RELATIONSHIP BETWEEN THE ELECTROENCEPHALOGRAM AND THE REGIONAL CEREBRAL BLOOD FLOW
  125. METRIZAMID MYELOGRAPHY IN PATIENTS WITH MENINGEAL CARCINOMATOSIS
  126. MECHANISM OF ACTION OF AMINO-PHYLLINE AND OF HYPOCAPNIA ON CEREBROVASCULAR DISEASE
  127. 875 CASES OF BACTERIAL MENINGITIS AT THE BLEGDAMSHOSPITAL 1966-76. PROGNOSIS AND FOLLOW-UP.
  128. CHARACTERISTICS OF THE GRADUALLY SPREADING REDUCTION OF REGIONAL CEREBRAL BLOOD FLOW IN CLASSIC MIGRAINE.
  129. Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents
  130. ELECTROPHYSIOLOGICAL FINDINGS IN MYASTHENIA GRAVIS FOLLOWING PLASMA EXCHANGE
  131. INTRACRANIAL METASTASES IN SMALL CELL LUNG CANCER.
  132. MISONIDAZOLE NEUROPATHY - A PROSPECTIVE STUDY:
  133. MISONIDAZOLE NEUROPATHY:
  134. PLASMA PYRIDOSTIGMINE LEVELS IN MYASTHENIA GRAVIS.
  135. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography
  136. Differences in Characteristics of Blood-Brain Barrier Permeability for Glucose and Amino Acids
  137. The Effect of Extracranial-intracranial Bypass on Cerebral Blood Flow
  138. BRAIN MAPPING BY EMISSION COMPUTERIZED TOMOGRAPHY: (ECT) OF INHALED 133-XENON DURING ACTIVATION OF THE BRAIN CORTEX.
  139. CEREBRAL UPTAKE RATE OF ANTIEPILEPTIC DRUGS
  140. CHANGES IN FOCAL CEREBRAL BLOOD FLOW WITHIN THE INTERNAL CAROTID SYSTEM DURING MIGRAINE ATTACK
  141. FOCAL CEREBRAL BLOOD FLOW, REACTIVITY OF CEREBRAL BLOOD VESSELS AND CEREBRAL OXYDATIVE METABOLISM IN CERTAIN GROUPS OF PATIENTS WITH ORGANIC DEMENTIA
  142. MRI-Defined Subcortical Ischemic Vascular Disease: Baseline Clinical and Neuropsychological Findings
  143. Longitudinal Cognitive Decline in Subcortical Ischemic Vascular Disease – The LADIS Study
  144. Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates
  145. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
  146. Urinary Complaints in Nondisabled Elderly People with Age-Related White Matter Changes: The Leukoaraiosis And DISability (LADIS) Study
  147. On the Etiology of Incident Brain Lacunes: Longitudinal Observations From the LADIS Study
  148. White Matter Changes Contribute to Corpus Callosum Atrophy in the Elderly: The LADIS Study
  149. Comments on Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow
  150. Heart and brain circulation in healthy men are differently affected by CO2
  151. Segmentation of age-related white matter changes in a clinical multi-center study
  152. The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined
  153. Association of gait and balance disorders with age-related white matter changes: The LADIS Study
  154. Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study
  155. Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder
  156. Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study
  157. Alterations of the visual pathways in congenital blindness
  158. Reliability and Sensitivity of Visual Scales versus Volumetry for Evaluating White Matter Hyperintensity Progression
  159. Acute MRI Changes in Progressive Ischemic Stroke
  160. Is the Prefrontal Cortex Necessary for Establishing Cognitive Sets?
  161. Validation of in vitro probabilistic tractography
  162. Premotor cortex modulates somatosensory cortex during voluntary movements without proprioceptive feedback
  163. Watching Your Foot Move--An fMRI Study of Visuomotor Interactions during Foot Movement
  164. Structural brain abnormalities in early onset first-episode psychosis
  165. P2-253
  166. A prospective PET study of patients with glioblastoma multiforme
  167. Similar brain networks for detecting visuo-motor and visuo-proprioceptive synchrony
  168. Motor activation in SPG4-linked hereditary spastic paraplegia
  169. Correlation of Global N-Acetyl Aspartate With Cognitive Impairment in Multiple Sclerosis
  170. Global Cerebral Blood Flow and Metabolism during Acute Hyperketonemia in the Awake and Anesthetized Rat
  171. Magnetic Resonance Imaging at 3.0 Tesla Detects More Lesions in Acute Optic Neuritis Than at 1.5 Tesla
  172. Shape configuration and category-specificity
  173. Increased intracranial volume in Parkinson's disease
  174. Changes in BOLD and ADC weighted imaging in acute hypoxia during sea-level and altitude adapted states
  175. Decline in intelligence is associated with progression in white matter hyperintensity volume
  176. MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)
  177. Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia
  178. Global Cerebral Blood Flow and Metabolism during Acute Hyperketonemia in the Awake and Anesthetized Rat
  179. White matter hyperintensities and depression—preliminary results from the LADIS study
  180. Motion or activity: their role in intra- and inter-subject variation in fMRI
  181. Laser Doppler flowmetry is valid for measurement of cerebral blood flow autoregulation lower limit in rats
  182. Assessment of in vivo MR imaging compared to physical sections in vitro—A quantitative study of brain volumes using stereology
  183. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
  184. The relationship between cerebral blood flow and volume in humans
  185. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis
  186. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation
  187. Enhanced Accuracy in Novel Mirror Drawing after Repetitive Transcranial Magnetic Stimulation-Induced Proprioceptive Deafferentation
  188. Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences
  189. [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge
  190. Right Temporoparietal Cortex Activation during Visuo-proprioceptive Conflict
  191. Parieto–Occipital Areas Involved in Efficient Filtering in Search: A Time Course Analysis of Visual Marking using Behavioural and Functional Imaging Procedures
  192. A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables
  193. Structural similarity and category-specificity: a refined account
  194. Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats
  195. Blood–brain barrier, brain metabolism and cerebral blood flow
  196. Attentional effects in the visual pathways: a whole-brain PET study
  197. When Action Turns into Words. Activation of Motor-Based Knowledge during Categorization of Manipulable Objects
  198. Cortical Deactivation Induced by Visual Stimulation in Human Slow-Wave Sleep
  199. Regional cerebral blood flow during light sleep - a H215O-PET study
  200. Regulation of cerebral blood flow in patients with autonomic dysfunction and severe postural hypotension
  201. Hemodynamic and metabolic features of cerebral activation
  202. Oxygen delivery to the brain during behavioral activation at acute normobaric hypoxemia
  203. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat
  204. Quantification of [123I]PE2I binding to dopamine transporters with SPET
  205. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats
  206. Cluster analysis of activity-time series in motor learning
  207. Unchanged Cerebral Blood Flow and Oxidative Metabolism after Acclimatization to High Altitude
  208. The Role of Action Knowledge in the Comprehension of Artefacts— A PET Study
  209. Brain activity related to integrative processes in visual object recognition: bottom-up integration and the modulatory influence of stored knowledge
  210. Activation-Induced Resetting of Cerebral Metabolism and Flow Is Abolished by  -Adrenergic Blockade With Propranolol
  211. Idiopathic normal-pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic
  212. EFNS Task Force on Teaching of Neuroimaging in Neurology Curricula in Europe: present status and recommendations for the future
  213. No effect of angiotensin II AT2-receptor antagonist PD 123319 on cerebral blood flow autoregulation
  214. Using 10CO2 for Single Subject Characterization of the Stimulus Frequency Dependence in Visual Cortex: A Novel Positron Emission Tomography Tracer for Human Brain Mapping
  215. The 18F-fluorodeoxyglucose Lumped Constant Determined in Human Brain from Extraction Fractions of 18F-fluorodeoxyglucose and Glucose
  216. Integrative processes in visual object recognition
  217. Modified motor activation in autosomal dominant pure spastic paraplegia (ADPSP) using PET
  218. Blood-Brain Barrier Transport and Brain Metabolism of Glucose during Acute Hyperglycemia in Humans
  219. Benzodiazepine receptor quantification in Huntington's disease with [123I]iomazenil and SPECT
  220. Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the ε4 Allele on Regional Cerebral Blood Flow
  221. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
  222. Categorization and category effects in normal object recognition
  223. Brain Activation During Mental Transformation of Size
  224. Quantitation of Regional Cerebral Blood Flow Corrected for Partial Volume Effect Using O-15 Water and PET: II. Normal Values and Gray Matter Blood Flow Response to Visual Activation
  225. Quantitation of Regional Cerebral Blood Flow Corrected for Partial Volume Effect Using O-15 Water and PET: I. Theory, Error Analysis, and Stereologic Comparison
  226. Dopamine D2 receptor quantification in extrastriatal brain regions using [123I]epidepride with bolus/infusion
  227. Dopamine D2 receptor quantification in extrastriatal brain regions using [123I]epidepride with bolus/infusion
  228. Effects of attention on dichotic listening: An15O-PET study
  229. The role of action knowledge in the comprehension of artefacts— A PET study
  230. Attentional modulation in the early visual pathways
  231. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate
  232. Cerebral activation during micturition in normal men
  233. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS
  234. Regional Differences in the CBF and BOLD Responses to Hypercapnia: A Combined PET and fMRI Study
  235. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
  236. Reconstruction strategy for echo planar spectroscopy and its application to partially undersampled imaging
  237. Perceptual differentiation and category effects in normal object recognition: A PET study
  238. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
  239. Blood—Brain Barrier Transport and Protein Binding of Flumazenil and Iomazenil in the Rat: Implications for Neuroreceptor Studies
  240. High dose insulin does not increase glucose transfer across the blood-brain barrier in humans: a re-evaluation
  241. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS
  242. Determination of relative CMRO2 from CBF and BOLD changes: Significant increase of oxygen consumption rate during visual stimulation
  243. A multidisciplinary memory clinic in a neurological setting: diagnostic evaluation of 400 consecutive patients
  244. Generalizable Patterns in Neuroimaging: How Many Principal Components?
  245. Brain activation during dichotic presentations of consonant-vowel and musical instrument stimuli: a 15O-PET study
  246. The Kety–Schmidt technique for repeated measurements of global cerebral blood flow and metabolism in the conscious rat
  247. Maturation Phenomenon in Cerebral Ischemia III
  248. Parieto-occipital cortex activation during self-generated eye movements in the dark
  249. Differential Effects of Migraine Drugs on Cerebral Blood Flow Autoregulation
  250. Activation-Induced Resetting of Cerebral Oxygen and Glucose Uptake in the Rat
  251. Brain Activation during Word Identification and Word Recognition
  252. Calculation of the FDG Lumped Constant by Simultaneous Measurements of Global Glucose and FDG Metabolism in Humans
  253. Cerebral blood volume in humans by NIRS and PET
  254. Functional Brain Imaging With Single-Photon Emission Computed Tomography in the Diagnosis of Alzheimers Disease
  255. The activation pattern in normal humans during suppression, imagination and performance of saccadic eye movements
  256. Niels A. Lassen, M.D., Ph.D. 1926–1997
  257. Differential Effects of Increasing Doses of α-Trinositol on Cerebral Blood Flow Autoregulation
  258. Cerebral metabolism in a case of multiple sclerosis with acute mental disorder
  259. Rate Dependence of Regional Cerebral Activation during Performance of a Repetitive Motor Task: A PET Study
  260. Interictal SPECT of rCBF is of clinical utility in the preosperative evaluation of patients with partial epilepsy
  261. Antihypertensive drugs and cerebral circulation
  262. Dissociated cerebral vasoparalysis in acute liver failure
  263. Transport of D-Glucose and 2-Fluorodeoxyglucose across the Blood-Brain Barrier in Humans
  264. Cerebral Glucose Metabolism Is Decreased in White Matter Changes in Patients with Phenylketonuria
  265. EC-IC bypass in patients with chronic hemodvnamic insufficiency
  266. Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.
  267. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria
  268. Cerebral blood flow in untreated and treated hypertension
  269. Cerebral blood flow autoregulation and transcranial doppler sonography in patients with cirrhosis*1
  270. Neuroreceptor quantification in vivo by the steady state principle and [123I]iomazenil in rats
  271. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans
  272. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation
  273. Persistent Resetting of the Cerebral Oxygen/Glucose Uptake Ratio by Brain Activation: Evidence Obtained with the Kety—Schmidt Technique
  274. Cerebrovascular Damage in Hypertension
  275. Cerebrovascular damage in hypertension
  276. Regional Cerebral Blood Flow and Neuropsychological Performance in a Danish Family with X-Linked Bulbo-Spinal Neuronopathy
  277. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
  278. Hypercapnic vasodilatation in isolated rat basilar arteries is exerted via low pH and does not involve nitric oxide synthase stimulation or cyclic GMP production
  279. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation
  280. Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type
  281. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats
  282. Cerebrovascular consequences of hypertension
  283. Comparison of the effects of NG-nitro-L-arginine and indomethacin on the hypercapnic cerebral blood flow increase in rats
  284. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
  285. Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure
  286. Cerebral Ischemia and Basic Mechanisms
  287. The Effect of Tirilazad Mesylate (U74006F) on Cerebral Oxygen Consumption, and Reactivity of Cerebral Blood Flow to Carbon Dioxide in Healthy Volunteers
  288. Indomethacin Abolishes Cerebral Blood Flow Increase in Response to Acetazolamide-Induced Extracellular Acidosis: A Mechanism for its Effect on Hypercapnia?
  289. High resolution SPECT with [99mTc]-d,l-HMPAO in normal pressure hydrocephalus before and after shunt operation.
  290. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy
  291. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy
  292. Ceranapril and cerebral blood flow autoregulation
  293. Thalamic infarcts: Effects on cerebral blood flow, metabolism, and neuropsychological function
  294. Nitric oxide does not act as a mediator coupling cerebral blood flow to neural activity following somatosensory stimuli in rats
  295. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.
  296. Effect of Nitric Oxide Blockade by NG-Nitro-l-Arginine on Cerebral Blood Flow Response to Changes in Carbon Dioxide Tension
  297. Increased Cerebral Blood Flow in Anemic Patients on Long-Term Hemodialytic Treatment
  298. Is autoregulation of cerebral blood flow in rats influenced by nitro-l-arginine, a blocker of the synthesis of nitric oxide?
  299. The effect of ketanserin on cerebral blood flow and cerebrovascular CO2 reactivity in healthy volunteers
  300. Cerebral Blood Flow Deficits in Hereditary Essential Myoclonus
  301. Extracranial-Intracranial Bypass Revisited
  302. Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats
  303. Effect of ketanserin on cerebral blood flow autoregulation in healthy volunteers
  304. Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population Survey
  305. Kinetic Analysis of the Human Blood-Brain Barrier Transport of Lactate and its Influence by Hypercapnia
  306. Regional Density of Perfused Capillaries and Cerebral Blood Flow in Untreated Short-Term and Long-Term Streptozotocin Diabetes
  307. 99mTc-d,l-HMPAO and SPECT of the Brain in Normal Aging
  308. The acute effect of nimodipine on cerebral blood flow, its CO2 reactivity, and cerebral oxygen metabolism in human volunteers
  309. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors
  310. Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers
  311. Asymmetrical Transport of Amino Acids across the Blood—Brain Barrier in Humans
  312. The Effect of Fosinopril Sodium on Cerebral Blood Flow in Moderate Essential Hypertension
  313. Computerized Analysis of Cerebral Blood Flow Autoregulation in Humans
  314. The Acute Effect of Dilevalol on Cerebral Blood Flow and Oxygen Consumption in Normotensive Humans
  315. Angiotensin converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalus
  316. Kinetic analysis of blood-brain barrier transport of d-glucose in man: Quantitative evaluation in the presence of tracer backflux and capillary heterogeneity
  317. Involuntary Movements
  318. Angiotensin-Converting Enzyme Inhibition and Regional Cerebral Blood Flow in Acute Stroke
  319. Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation
  320. Neuronal pH Regulation: Constant Normal Intracellular pH is Maintained in Brain during Low Extracellular pH Induced by Acetazolamide—31P NMR Study
  321. Cerebral circulation under normal and pathologic conditions
  322. Angiotensin converting enzyme inhibition and cerebral circulation-a review.
  323. Metabolic Disturbances of the Blood-Brain Barrier with Special Emphasis on Glucose and Amino Acid Transport
  324. Cerebral Ischemia and Calcium
  325. Misonidazole neuropathy A prospective study
  326. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy
  327. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow?
  328. Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting
  329. Methods for Measurement of Cerebral Blood Flow
  330. Antihypertensive Treatment and the Cerebral Circulation
  331. Antihypertensive Treatment and the Cerebral Circulation
  332. Methods for Measurement of Cerebral Blood Flow
  333. Decreased Blood-Brain Barrier Permeability to Sodium in Early Experimental Diabetes
  334. Cerebral blood flow in acute and chronic ischemic stroke using xenon-133 inhalation tomography
  335. DOES ANGIOTENSIN-II PROTECT AGAINST STROKES?
  336. Effect of captopril on the cerebral circulation in chronic heart failure
  337. Calcium Antagonist (PY 108-068) Treatment May Further Decrease Flow in Ischemic Areas in Acute Stroke
  338. Regional cerebral blood flow in acute experimental allergic encephalomyelitis
  339. A Spatial Analysis of the Blood—Brain Barrier Damage in Experimental Allergic Encephalomyelitis
  340. Observations on regional cerebral blood flow in cortical and subcortical structures during language production in normal man
  341. CBF before and after extracranial-intracranial bypass surgery in patients with ischemic cerebrovascular disease studied with 133Xe- inhalation tomography
  342. Pneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae
  343. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri)
  344. FOCAL INCREASE OF BLOOD FLOW IN THE CEREBRAL CORTEX OF MAIN DURING VESTIBULAR STIMULATION
  345. Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis
  346. Cerebral Blood Flow and Metabolism Measurement
  347. Cerebrovascular Aspects of Converting-enzyme Inhibition II: Blood-brain Barrier Permeability and Effect of Intracerebroventricular Administration of Captopril
  348. Cerebrovascular Aspects of Converting-enzyme Inhibition I: Effects of Intravenous Captopril in Spontaneously Hypertensive and Normotensive Rats
  349. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen.
  350. Pneumococcal Meningitis
  351. Steady state kinetics of pyridostigmine in myasthenia gravis
  352. Converting Enzyme Inhibition and Autoregulation of Cerebral Blood Flow in Spontaneously Hypertensive and Normotensive Rats
  353. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat
  354. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats
  355. Cerebral blood flow in patients with congestive heart failure treated with captopril
  356. Cerebral autoregulation
  357. Regional Cerebral Blood Flow Measured by Xenon-133 and [123I]Iodo-Amphetamine in Patients with Cerebrovascular Diseases
  358. Cerebral blood flow during dihydralazine-induced hypotension in hypertensive rats
  359. Regulation of regional cerebral blood flow during and between migraine attacks
  360. Whole blood viscosity and cerebral blood flow
  361. Secondary brain stem hemorrhage in stroke
  362. Changes in regional cerebral blood flow during the course of classic migraine attacks
  363. Intracranial metastases in small cell carcinoma of the lung prognostic aspects
  364. Controlled Hypotension with Sodium Nitroprusside: Effects on Cerebral Blood Flow and Cerebral Venous Blood Gases in Patients Operated for Cerebral Aneurysms
  365. The Indicator Dilution Method: Assumptions and Applications to Brain Uptake
  366. Tracer Kinetics and Physiologic Modeling
  367. Intracranial metastases in small cell carcinoma of the lung. Correlation of clinical and autopsy findings
  368. Transfer across the human blood-brain barrier: Evidence for capillary recruitment and for a paradox glucose permeability increase in hypocapnia
  369. The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases.
  370. The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases.
  371. Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs
  372. Arterial and venous concentrations of phenobarbital, phenytoin, clonazepam, and diazepam after rapid intravenous injections
  373. Letter to the Editor
  374. Misonidazole neuropathy: A clinical, electrophysiological and histological study
  375. Invasive Adenoma of the Pituitary Gland and Chronic Migrainous Neuralgia. A Rare Coincidence or a Causal Relationship?
  376. Rapid improvement of myasthenia gravis after plasma exchange
  377. Amphotericin B and the Blood-Brain Barrier to Methotrexate
  378. Amphotericin B and the Blood-Brain Barrier to Methotrexate
  379. Reply
  380. Visual cortex activation recorded by dynamic emission computed tomography of inhaled xenon 133
  381. Note by Editors-in-Chief
  382. Blood-brain barrier permeability of L-dopa in man
  383. Cerebral blood flow following normavolemic hemodilution in patients with high hematocrit
  384. Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography
  385. Insulin increases glucose transfer across the blood-brain barrier in man.
  386. Essential tremor treated with propranolol: Lack of correlation between clinical effect and plasma propranolol levels
  387. The role of unstirred layers for water exchange across the blood-brain barrier
  388. Orbital bruits and retinal artery pressure in internal carotid artery occlusion
  389. insulin influence the cerebral uptake of glucose.
  390. RECENT ADVANCES IN THE DIAGNOSIS OF CEREBROVASCULAR DISEASE
  391. THE BLOOD-BRAIN BARRIER:AN OVERVIEW WITH SPECIAL REFERNCE TO INSULIN EFFECTS ON GLUCOSE TRANSPORT
  392. Carbon dioxide permeability of the blood-brain barrier in man
  393. Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood-brain barrier permeability.
  394. CEREBROVASCULAR RESPONSES: MISCELLANEOUS TOPICS
  395. Neuro-Oncology
  396. CHAPTER X: CEREBROVASCULAR RESPONSES: MISCELLANEOUS TOPICS
  397. Blood-brain barrier permeability during shortlasting intravascular hyperosmolality
  398. CHAPTER VIII STROKE
  399. DOES ALEXIA WITHOUT AGRAPHIA ALWAYS INCLUDE HEMIANOPSIA?
  400. The permeability of the blood—brain barrier during electrically induced seizures in man
  401. Filtration and diffusion of water across the blood-brain barrier in man
  402. Ophthalmodynamometry in internal carotid artery occlusion
  403. NATURAL HISTORY OF MICTURITION SYNCOPE
  404. Cerebral Circulation and Metabolism
  405. The Mechanism of Cerebral Hyperemia in Electrically Induced Epileptic Seizures in Man
  406. Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls
  407. Traitements des maladies cérébro-vasculaires : aperçus au sujet des lésions ischémiques et des hématomes intracérébraux
  408. Regional cerebral blood flow in cerebral infarction and in transient ischemic attacks
  409. Normal and abnormal relationship between the electroencephalogram (EEG) and the regional cerebral blood flow (rCBF)
  410. Conclusions générales
  411. Cerebral Vasomotor Paralysis During Migraine Attack
  412. CEREBRAL BLOOD FLOW AND METABOLISM IN ELECTROCONVULSIVE THERAPY
  413. Cerebral Apoplexy (Stroke) Treated With or Without Prolonged Artificial Hyperventilation: 2. Cerebrospinal Fluid Acid-Base Balance and Intracranial Pressure
  414. Cerebral Apoplexy (Stroke) Treated With or Without Prolonged Artificial Hyperventilation: 1. Cerebral Circulation, Clinical Course, and Cause of Death
  415. Cerebral Hyperemia in Electrically Induced Epileptic Seizures
  416. The Effect of Intracarotid Aminophylline Infusion on the Cerebral Circulation
  417. Prolonged Artificial Hyperventilation in Severe Cerebral Apoplexy
  418. Restoration of autoregulation of cerebral blood flow by hypocapnia
  419. Intracranial Hypertension
  420. Regional Cerebral Blood Flow in Man Determined by the Initial Slope of the Clearance of Intra-arterially Injected l33Xe: THEORY OF THE METHOD, NORMAL VALUES, ERROR OF MEASUREMENT, CORRECTION FOR REMAINING RADIOACTIVITY, RELATION TO OTHER FLOW PARAMETER...
  421. Cerebral Apoplexy (Stroke): Pathogenesis, Pathophysiology and Therapy as Illustrated by Regional Blood Flow Measurements in the Brain
  422. The Effect of Intra-arterial Papaverine on the Regional Cerebral Blood Flow in Patients with Stroke or Intracranial Tumor
  423. REGIONAL CEREBRAL BLOOD FLOW AND ITS REGULATION IN DEMENTIA
  424. TOTAL CO2, LACTATE, AND PYRUVATE IN BRAIN BIOPSIES TAKEN AFTER FREEZING THE TISSUE IN SITU
  425. THE MECHANISM OF ACTION OF AMINOPHYLLINE UPON CEREBRAL VASCULAR DISORDERS
  426. Regional cerebral blood flow and its autoregulation in patients with transient focal cerebral ischemic attacks
  427. Regional cerebral blood flow in apoplexy without arterial occlusion
  428. Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery
  429. Regional blood flow in internal carotid distribution during migraine attack.
  430. Carbon Dioxide and Cerebral Circulatory Control
  431. THE METABOLISM OF GLUCOSE AND OTHER METABOLITES IN THE BRAIN OF PATIENTS WITH CEREBRAL ARTERIOSCLEROSIS AND OF PATIENTS WITH DIABETES MELLITUS
  432. The Local Site of Action of CO2on Cerebral Circulation Evidenced by Changing the Internal Carotid Artery pCO2in Awake Human Subjects
  433. Regional Cerebral Blood Flow in Middle Cerebral Artery Occlusion
  434. Regional Cerebral Blood Flow in Apoplexy (Acute Hemiparesis) without Arterial Occlusion
  435. Discussion and Comments to Section XI on Techniques for Measurement of Cerebral Blood Flow
  436. Regional Cerebral Blood Flow in Acute Apoplexy
  437. Measurement of blood–brain barrier in humans using indicator diffusion